Anúncio
Anúncio
VRTX
Vertex Pharmaceuticals Inc
469.71
USDPatrocinado
-14.44
-2.98%
08 de jan., 16:00 UTC -5
Encerrado
Pós-Mercado
470.26
+0.55
+0.12%
Relatórios de Lucros VRTX
Rácio de surpresa positiva
VRTX separação 30 de 39 últimas estimativas.
77%
Próximo Relatório
Data do Próximo Relatório
04 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.24B
/$5.20
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+5.43%
/+8.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+11.39%
/+30.65%
Vertex Pharmaceuticals Inc earnings per share and revenue
On 03 de nov. de 2025, VRTX reported earnings of 4.80 USD per share (EPS) for Q3 25, beating the estimate of 4.65 USD, resulting in a 3.12% surprise. Revenue reached 3.08 bilhão, compared to an expected 3.11 bilhão, with a -1.22% difference. The market reacted with a -1.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 31 analistas forecast an EPS of 5.20 USD, with revenue projected to reach 3.24 bilhão USD, implying an aumentar of 8.33% EPS, and aumentar of 5.43% in Revenue from the last quarter.
FAQ
What were Vertex Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vertex Pharmaceuticals Inc reported EPS of $4.80, beating estimates by 3.12%, and revenue of $3.08B, -1.22% below expectations.
How did the market react to Vertex Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved down -1.02%, changed from $426.00 before the earnings release to $421.67 the day after.
When is Vertex Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for 04 de fev. de 2026.
What are the forecasts for Vertex Pharmaceuticals Inc's next earnings report?
Based on 31
analistas, Vertex Pharmaceuticals Inc is expected to report EPS of $5.20 and revenue of $3.24B for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio